Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. pelabdisk

peLabDisk

Point-of-care molecular diagnostics of psoriasis and eczema – peLabDisk

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 peLabDisk project word cloud

Explore the words cloud of the peLabDisk project. It provides you a very rough idea of what is the project "peLabDisk" about.

treat    exist    entrepeneurship    medicine    expertise    schickard    hahn    imcis    manufacturing    competence    supervised    treatment    strategy    ineffective    company    676858    microfluidic    eczema    socio    cartridges    psoriasis    post    diagnostic    off    individual    created    construction    individualised    foundation    harmful    wrong    feasible    grant    roadmap    consists    first    lack    distinguish    substantial    decades    superior    therapies    valid    consequence    packages    ncisd    munich    poc    innovation    unguided    care    innovative    milestones    disease    point    network    prototype    distinguished    made    biomarker    spin    biological    patients    heterogeneity    mis    imprecise    clear    experts    communicable    closes    signature    guidance    inefficient    waste    caused    diagnostics    molecular    follows    gold    erc    gap    university    extensive    diseases    diagnosis    plan    economic    handle    joint    skin    establishing    standard    therapy    forces    10    pelabdisk    medical    device    tum    inflammatory    treating   

Project "peLabDisk" data sheet

The following table provides information about the project.

Coordinator		 KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN 

Organization address
address: ISMANINGER STRASSE 22
city: MUENCHEN
postcode: 81675
website: http://www.med.tu.muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Germany [DE]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2018
 Duration (year-month-day) from 2018-03-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN DE (MUENCHEN) coordinator 150˙000.00

Map

 Project objective

Innovative and effective biological therapies exist to treat non-communicable inflammatory skin diseases (ncISD). However, diagnostic guidance when and how to use them is imprecise; no substantial innovation was made for decades. Due to this lack of innovation, high socio-economic costs are caused by ineffective unguided treatment – a waste of resources. Existing ERC research aims at establishing individualised medicine in ncISD (IMCIS, grant agreement 676858). First success is a biomarker to distinguish psoriasis from eczema. Due to disease heterogeneity, these two ncISD cannot be distinguished in 10% of all cases with current gold standard diagnostics. Treating patients with the wrong therapy as a consequence of mis-diagnosis is inefficient and might even be harmful. This PoC proposal follows the path of IMCIS and closes the gap between ERC research and a prototype device of a point-of-care microfluidic testing device to distinguish psoriasis and eczema based on their molecular signature (peLabDisk). The proposal is feasible, as there is a high level of expertise created by joint forces of researchers of the Technical University of Munich and Hahn-Schickard providing extensive competence in the development, construction and manufacturing of microfluidic cartridges for medical applications. The project plan consists of well-defined work packages and milestones. Furthermore, success of the individual work packages is supervised by experienced experts (TUM Entrepeneurship). This PoC proposal is not the end – there is a clear roadmap and a detailed strategy for the post-PoC phase including potential end-user network and supported foundation of a spin-off company. peLabDisk represents the first approach of molecular diagnostics in the field that is easy-to-handle, robust and valid, as well as economic. It is superior to current gold standard diagnostics. Furthermore, peLabDisk is a use-case for point-of-care molecular diagnostics in complex inflammatory diseases.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PELABDISK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PELABDISK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More  

IMMUNOTHROMBOSIS (2019)

Cross-talk between platelets and immunity - implications for host homeostasis and defense

Read More  

RODRESET (2019)

Development of novel optogenetic approaches for improving vision in macular degeneration

Read More